Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-phenyl-5-(trideuteriomethyl)-1,2-dihydropyridin-2-one
2. 5-methyl-1-phenyl-2-(1h)-pyridone
3. Deskar
4. Esbriet
5. Pirfenidone
1. 1qc36bhi6s
2. Lyt-100
3. 1093951-85-9
4. 2(1h)-pyridinone, 5-(methyl-d3)-1-phenyl-
5. 1-phenyl-5-(trideuteriomethyl)-1,2-dihydropyridin-2-one
6. Deupirfenidone [usan]
7. Unii-1qc36bhi6s
8. Lyt100
9. Schembl4059454
10. Deupirfenidone [who-dd]
11. Sd-560
12. Who 12460
13. At18410
| Molecular Weight | 188.24 g/mol |
|---|---|
| Molecular Formula | C12H11NO |
| XLogP3 | 1.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 1 |
| Exact Mass | 188.102894212 g/mol |
| Monoisotopic Mass | 188.102894212 g/mol |
| Topological Polar Surface Area | 20.3 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 285 |
| Isotope Atom Count | 3 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Deupirfenidone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deupirfenidone, including repackagers and relabelers. The FDA regulates Deupirfenidone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deupirfenidone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Deupirfenidone supplier is an individual or a company that provides Deupirfenidone active pharmaceutical ingredient (API) or Deupirfenidone finished formulations upon request. The Deupirfenidone suppliers may include Deupirfenidone API manufacturers, exporters, distributors and traders.
Deupirfenidone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Deupirfenidone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Deupirfenidone GMP manufacturer or Deupirfenidone GMP API supplier for your needs.
A Deupirfenidone CoA (Certificate of Analysis) is a formal document that attests to Deupirfenidone's compliance with Deupirfenidone specifications and serves as a tool for batch-level quality control.
Deupirfenidone CoA mostly includes findings from lab analyses of a specific batch. For each Deupirfenidone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Deupirfenidone may be tested according to a variety of international standards, such as European Pharmacopoeia (Deupirfenidone EP), Deupirfenidone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Deupirfenidone USP).
LOOKING FOR A SUPPLIER?
